Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
March 27, 2019 Off

Chemotherapy Induced Neutropenia Pipeline Review, H1 2019 Edition – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Chemotherapy Induced Neutropenia – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Chemotherapy Induced…

March 27, 2019 Off

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) – Pipeline Review, H1 2019 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering.…

March 27, 2019 Off

KalVista Pharmaceuticals Announces the Promotion of Benjamin L. Palleiko to Include Chief Business Officer

By BusinessWire

CAMBRIDGE, Mass. & SALISBURY, England–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24KALV&src=ctag" target="_blank"gt;$KALVlt;/agt;–KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the…

March 27, 2019 Off

Promethera Biosciences Announces Late-Breaking Data Presentation at EASL 2019 from World First Liver Stem Cell Clinical Trial in ACLF

By BusinessWire

Interim safety data together with early signals of efficacy will be presented in oral presentation at The International Liver Congress™…

March 27, 2019 Off

Veeva Vault CDMS Selected for Vivozon’s VVZ-149 Studies

By BusinessWire

Veeva Vault CDMS to manage clinical data for phase 2 and phase 3 post-operative pain trials PLEASANTON, Calif.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/CDMS?src=hash"…

March 27, 2019 Off

Juvenescence Capitalizes BYOMass Inc. with up to $6.5 million

By BusinessWire

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Juvenescence Ltd, a biopharmaceutical company focused on treating aging and age-related disease, is pleased to announce its latest…

Clinigen’s Foscavir® gains approval for HHV-6 encephalitis in Japan
March 27, 2019 Off

Clinigen’s Foscavir® gains approval for HHV-6 encephalitis in Japan

By BusinessWire

BURTON-UPON-TRENT, England–(BUSINESS WIRE)–Clinigen Group plc (AIM: CLIN, ‘Clinigen’), the global pharmaceutical and services company, announces that Foscavir (foscarnet sodium) has…

Janssen Seeks Expanded Use of DARZALEX®▼ (daratumumab) Combination Therapy for Newly Diagnosed, Transplant Eligible Patients with Multiple Myeloma
March 27, 2019 Off

Janssen Seeks Expanded Use of DARZALEX®▼ (daratumumab) Combination Therapy for Newly Diagnosed, Transplant Eligible Patients with Multiple Myeloma

By BusinessWire

First DARZALEX combination regimen being pursued as frontline treatment option for transplant eligible patients with multiple myeloma BEERSE, Belgium–(BUSINESS WIRE)–The…

Gilead to Present New Data From Multiple Liver Disease Research and Development Programs at The International Liver Congress™ 2019
March 27, 2019 Off

Gilead to Present New Data From Multiple Liver Disease Research and Development Programs at The International Liver Congress™ 2019

By BusinessWire

— More Than 35 Abstracts Across NASH, PSC and Viral Hepatitis Reflect Ongoing Commitment to Advancing Liver Disease Research and…

March 27, 2019 Off

Innovus Pharmaceuticals to Release its Annual 2018 Financial Results on Monday, April 1, 2019

By BusinessWire

SAN DIEGO–(BUSINESS WIRE)–Innovus Pharmaceuticals, Inc. (“Innovus Pharma”) (OTCQB: INNVD), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective…

Posts pagination

Previous 1 … 3,327 3,328 3,329 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine